Article Text

Download PDFPDF

Mediastinal involvement in ovarian cancer
Free
  1. Nwabundo Nwankwo,
  2. Alan D Gilman,
  3. Aibek E Mirrakhimov,
  4. Nkemakolam A Iroegbu
  1. Department of Internal Medicine, Saint Joseph Hospital, Chicago, Illinois, USA
  1. Correspondence to Dr Aibek E Mirrakhimov, amirrakhimov1{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

A 57-year-old woman was diagnosed with serous papillary ovarian adenocarcinoma, for which she underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy and appendectomy (omentum, appendix and other organs other than left ovary were grossly normal). CT scan of the chest was done, which showed prevascular lymph node measuring up to 4.5 cm (figure 1). The lymph node was biopsied, which stained positive for cytokeratin 7 and Wilms tumor gene product (WT)-1, which consistent with metastatic ovarian adenocarcinoma (figure 2). The patient was recently started on chemotherapy including carboplatin and paclitaxel, and radiation therapy.

Figure 1

CT scan of the chest showing prevascular lymph node (red arrow).

Figure 2

The lymph node biopsy consistent with metastatic ovarian carcinoma.

Ovarian cancer is the second most common gynaecological cancer after breast cancer and the leading cause of gynaecological cancer-related deaths.1 Lymphatic spread and direct peritoneal tumour seeding are the most common metastatic routes of ovarian cancer.2 Mediastinal involvement is a rare phenomenon in patients with ovarian adenocarcinoma, with a few reports being published in the scientific literature.3–6

Mediasintal involvement is an ominous sign, which indicates an advanced disease stage and poor prognosis. Clinicians should be aware that mediastinum may be involved in cases of ovarian cancer, even after performing debulking surgery for a primary ovarian tumour such as in our case.

Learning points

  • Ovarian cancer is the second most common gynaecological malignancy, being the leading cause of gynaecological cancer-related mortality.

  • Lymphatic spread and direct peritoneal tumour seeding are the most common metastatic routes of ovarian cancer.

  • Mediastinal involvement is rare in patients with ovarian cancer, yet possible. Mediastinal involvement is associated with advanced disease stage and poor prognosis.

References

View Abstract

Footnotes

  • Contributors Each author contributed equally to this manuscript.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.